Developments and Challenges in Durable Ventricular Assist Device Technology: A Comprehensive Review with a Focus on Advancements in China

Jingrong Tu,Li Xu,Fei Li,Nianguo Dong

DOI: https://doi.org/10.3390/jcdd11010029

2024-01-18

Journal of Cardiovascular Development and Disease

Abstract:Heart transplantation is currently the most effective treatment for end-stage heart failure; however, the shortage in donor hearts constrains the undertaking of transplantation. Mechanical circulatory support (MCS) technology has made rapid progress in recent years, providing diverse therapeutic options and alleviating the dilemma of donor heart shortage. The ventricular assist device (VAD), as an important category of MCS, demonstrates promising applications in bridging heart transplantation, destination therapy, and bridge-to-decision. VADs can be categorized as durable VADs (dVADs) and temporary VADs (tVADs), according to the duration of assistance. With the technological advancement and clinical application experience accumulated, VADs have been developed in biocompatible, lightweight, bionic, and intelligent ways. In this review, we summarize the development history of VADs, focusing on the mechanism and application status of dVADs in detail, and further discuss the research progress and use of VADs in China.

cardiac & cardiovascular systems

What problem does this paper attempt to address?

### Problems Addressed by the Paper

The paper primarily explores the development of durable Ventricular Assist Device (dVAD) technology and its application in China. Specifically, the paper aims to address the following aspects:

1. **Background and Challenges**:
- Heart Failure (HF) is the terminal stage symptom of various chronic Cardiovascular Diseases (CVDs), and the number of heart failure patients in China continues to increase.
- Heart transplantation is currently the most effective treatment, but due to the shortage of donor hearts, this treatment method is severely limited.
- Mechanical Circulatory Support (MCS) technology has made significant progress in recent years, providing multiple treatment options for heart failure patients and alleviating the shortage of donor hearts.

2. **Development History of dVAD Technology**:
- A detailed review of the historical development of dVAD technology, including the technical characteristics and clinical applications of the first, second, and third generations of dVAD.
- The first generation of dVAD had issues such as large size, high noise, and component damage.
- The second generation of dVAD achieved Continuous Flow (CF) through axial flow centrifugal pump technology, significantly improving patient survival rates and quality of life.
- The third generation of dVAD uses magnetic levitation or hydrodynamic suspension technology, further reducing blood component damage and lowering the risk of thrombosis.

3. **Current Status of dVAD Technology**:
- Describes the application of dVAD in different countries, especially the usage rates in the United States and Europe.
- Analyzes the application trends of dVAD as Bridge-to-Transplant (BTT), Destination Therapy (DT), and Bridge-to-Decision (BTD).

4. **Adverse Events Related to dVAD and Management Strategies**:
- Discusses a series of complications that may occur after dVAD implantation, such as gastrointestinal bleeding, stroke, device thrombosis, and driveline infections.
- Proposes management strategies for these complications to optimize patient outcomes.

5. **Development and Application of dVAD Technology in China**:
- Summarizes the research progress and clinical application of dVAD technology in China.
- Emphasizes China's innovations and breakthroughs in dVAD technology, particularly in biocompatibility, lightweight design, bionics, and intelligence.

Through the above content, the paper aims to comprehensively review the development history of dVAD technology, analyze its application status globally, especially in China, and propose future development directions and challenges.